Profit: Gene therapy for intervertebral disc degeneration (Q3301670): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
Profit: Gene therapy for intervertebral disc degeneration | |||
Revision as of 17:18, 24 October 2021
Project Q3301670 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Profit: Gene therapy for intervertebral disc degeneration |
Project Q3301670 in Germany |
Statements
9,991.27 Euro
0 references
1,248,908.31 Euro
0 references
0.8 percent
0 references
1 December 2019
0 references
30 June 2022
0 references
Genequine Biotherapeutics GmbH
0 references
Luckenwalde, Stadt
0 references
Identifiers
DE_TEMPORARY_4472
0 references